Skip to main content
. Author manuscript; available in PMC: 2016 Nov 6.
Published in final edited form as: J Vasc Interv Radiol. 2014 Mar 7;25(7):1056–1066. doi: 10.1016/j.jvir.2014.01.010

Table 2. Survival across HCC staging systems.

Staging System Categories Number of Patients (%) Median Survival in Months P-value (log rank)
Child-Pugh A 201 (47) 15.7 <0.0001
B 215 (50) 7.7
C 12 (3) 2.5
BCLC A 98 (23) 26.9 <0.0001
B 122 (28) 15.1
C 196 (46) 7.4
D 12 (3) 2.5
UNOS T1 5 (2) - <0.0001
T2 99 (23) 20.5
T3 65 (15) 19.9
T4a 82 (19) 13.5
T4b 126 (29) 6.5
M 51 (12) 6
CLIP Score 0 44 (10) 30.3 <0.0001
1 113 (26) 17.1
2 115 (27) 14.1
3 79 (18) 7.7
4 58 (14) 3.6
5 17 (4) 4.8
6 2 (1) 2.4
GRETCH A 95 (22) 22.7 <0.0001
B 239 (56) 11.8
C 94 (22) 4.5
CUPI Low Risk 347 (81) 14.1 <0.0001
Intermediate Risk 72 (17) 4.9
High Risk 9 (2) 2.3
JIS Score 0 2 (1) - <0.0001
1 53 (12) 26.9
2 85 (20) 27.5
3 139 (32) 11.2
4 140 (33) 6.3
5 9 (2) 2.5
Okuda 1 151 (35) 17.7 <0.0001
2 266 (62) 8.7
3 11 (3) 2.3

Abbreviations: BCLC: Barcelona Clinic Liver Cancer; CLIP: Cancer of the Liver Italian Program; CTP: Child-Turcotte- Pugh; CUPI: Chinese University Prognostic Index; GRETCH: Group d'Etude et de Traitement du Carcinome Hepatocellulaire; JIS: Japanese Integrated System; UNOS: United Network for Organ Sharing